<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(B) OR (G) OF THE
SECURITIES EXCHANGE ACT OF 1934
Pain Therapeutics, Inc.
(Exact name of Registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 91-1911336
- ---------------------------------------- ------------------------------------
(State of Incorporation or organization) (I.R.S. Employer Identification No.)
250 East Grand Avenue, Suite 70, South San Francisco, California 94080
- ---------------------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
</TABLE>
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
- --------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, $0.001 PAR VALUE
- --------------------------------------------------------------------------------
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered.
Incorporated by reference to Description of Capital Stock section and
Shares Eligible for Future Sales sections on pages 54 to 59 of the
Registrant's Registration Statement on Form S-1 filed with the Securities
and Exchange Commission on March 14, 2000, as amended (file number
333-32370) (the "S-1 Registration Statement").
Item 2. Exhibits.
The following exhibit is filed as a part of this Registration Statement:
<TABLE>
<S> <C>
*1.1 Specimen of Registrant's Common Stock Certificate.
*2.1 Form of Amended and Restated Certificate of Incorporation of
Registrant to be filed with the Secretary of State of Delaware
upon closing of the Registrant's initial public offering.
*2.2 Form of Amended and Restated By Laws of Registrant to be in
effect upon closing of Registrant's initial public offering.
*2.3 Second Amended and Restated Investors' Rights Agreement dated
February 1, 2000 between Registrant and the holders of its Series
B and C redeemable convertible preferred stock.
</TABLE>
* Incorporated by reference to the Exhibits to the S-1 Registration Statement.
-2-
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.
Dated: March 14, 2000 Pain Therapeutics, Inc.
By: /s/ REMI BARBIER
-------------------------------------
Remi Barbier,
President, Chief Executive Officer
And Chairman
